David Zaccardelli
Chief Executive Officer bij VERONA PHARMA PLC
Vermogen: 144 M $ op 31-03-2024
Profiel
David S.
Zaccardelli is currently the President, CEO & Executive Director at Verona Pharma Plc since 2020.
He is also currently serving as a Director at Elucida Oncology, Inc. since 2021 and at Evecxia, Inc. since 2016.
Previously, Dr. Zaccardelli held the position of Chief Executive Officer & Director at Cempra, Inc. from 2016 to 2017.
He was also the President, Chief Executive Officer & Director at Dova Pharmaceuticals, Inc. from 2018 to 2019.
Additionally, he served as a Director at CoreRx, Inc. from 2015 to 2021.
Dr. Zaccardelli has also worked as the Director of Clinical & Scientific Affairs at Bausch & Lomb Pharmaceuticals, Inc. from 1996 to 1997.
He served as an Independent Director at Melinta Therapeutics, Inc. from 2016 to 2020.
Furthermore, he held the position of Chief Operating Officer & Executive Vice President at United Therapeutics Corp.
from 2004 to 2016.
Dr. Zaccardelli obtained his doctorate degree from the University of Michigan in 1988.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VERONA PHARMA PLC
14.90% | 01-02-2024 | 71 553 256 ( 14.90% ) | 144 M $ | 31-03-2024 |
Actieve functies van David Zaccardelli
| Bedrijven | Functie | Begin |
|---|---|---|
| VERONA PHARMA PLC | Chief Executive Officer | 01-02-2020 |
Evecxia, Inc.
 Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Director/Board Member | 01-06-2016 |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Director/Board Member | 29-04-2021 |
Eerdere bekende functies van David Zaccardelli
| Bedrijven | Functie | Einde |
|---|---|---|
CoreRx, Inc.
 CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | Director/Board Member | 01-01-2021 |
| MELINTA THERAPEUTICS, INC. | Director/Board Member | 20-04-2020 |
| DOVA PHARMACEUTICALS, INC. | Chief Executive Officer | 12-11-2019 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Chief Executive Officer | 01-11-2017 |
| UNITED THERAPEUTICS CORPORATION | Chief Operating Officer | 26-06-2016 |
Opleiding van David Zaccardelli
| University of Michigan | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| VERONA PHARMA PLC | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
CoreRx, Inc.
CoreRx, Inc. Miscellaneous Commercial ServicesCommercial Services CoreRx, Inc. offers drug product development and manufacturing services. It offers preformulation, formulation development, analytical and stability, manufacturing and packaging, and bioavailability services. The company was founded by Rob Trivedi, Todd R. Daviau, Jim Davis, Mark Licarde and Brian McMillan in 2006 and is headquartered in Clearwater, FL. | Commercial Services |
Bausch & Lomb Pharmaceuticals, Inc.
 Bausch & Lomb Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb Pharmaceuticals, Inc. develops, manufactures, and markets eye health products. It offers products such as contact lens, lens care, pharmaceuticals, cataract and vitreoretinal, and refractive surgery. The company is headquartered in Tampa, FL. | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
Evecxia, Inc.
Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Commercial Services |
